Form 4 for TXG 10x Genomics, Inc.

Accepted 2026-09-08 19:00:27 ET · period of report 2026-09-03 · accession 0001610717-26-000405 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-09-08 19:00	2026-09-03	TXG	STUELPNAGEL JOHN R	Dir	S - Sale	$61.75	-20.0K	328.4K	-6%	-$1.24M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2026-09-03	S	D	7,012	$60.66	341,424	D	—	—	(F1) This transaction was executed in multiple trades at prices ranging from $60.435 to $61.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
2	Common	Class A Common Stock	2026-09-03	S	D	6,814	$62.11	334,610	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $61.435 to $62.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3	Common	Class A Common Stock	2026-09-03	S	D	6,174	$62.61	328,436	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $62.50 to $62.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.